Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2011
At a glance
- Drugs Doxorubicin liposomal; Everolimus
- Indications Solid tumours
- Focus Adverse reactions
- 15 Sep 2011 Planned End Date changed from 1 Feb 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 30 Jun 2010 New trial record